Libin Yan
79 Qingchun Road
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Loss of SETD2-mediated downregulation of intracellular and exosomal miRNA-10b determines MAPK pathway activation and multidrug resistance in renal cancer.
Journal: Molecular carcinogenesis
Published: April 30, 2023
Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 09, 2023
Corrigendum: Transcription factors BARX1 and DLX4 contribute to progression of clear cell renal cell carcinoma via promoting proliferation and epithelial-mesenchymal transition.
Journal: Frontiers in molecular biosciences
Published: August 23, 2022
Erratum: Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum.
Journal: Theranostics
Published: January 06, 2022
Erratum: Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum.
Journal: Theranostics
Published: January 06, 2022
OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers.
Journal: Nucleic acids research
Published: July 29, 2021
Clinicopathological characteristics of androgen receptor splicing variant 7 (AR-V7) expression in patients with castration resistant prostate cancer: A systematic review and meta-analysis.
Journal: Translational oncology
Published: February 09, 2021
Comprehensive characterization of alternative splicing in renal cell carcinoma.
Journal: Briefings in bioinformatics
Published: December 18, 2020
Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial-Mesenchymal Transition.
Journal: Frontiers in molecular biosciences
Published: November 21, 2020
Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy.
Journal: European urology
Published: June 29, 2020
The clinicopathological significance and prognostic value of programmed death-ligand 1 in prostate cancer: a meta-analysis of 3133 patients.
Journal: Aging
Published: March 30, 2020
HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 21, 2020
Last Updated: 09/26/2026